2020 Q1 Form 10-Q Financial Statement

#000151741320000094 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $62.92M $45.56M
YoY Change 38.12% 40.17%
Cost Of Revenue $27.27M $19.72M
YoY Change 38.27% 28.21%
Gross Profit $35.66M $25.84M
YoY Change 38.01% 51.01%
Gross Profit Margin 56.67% 56.72%
Selling, General & Admin $33.34M $23.74M
YoY Change 40.43% 31.52%
% of Gross Profit 93.49% 91.88%
Research & Development $14.30M $10.18M
YoY Change 40.51% 27.52%
% of Gross Profit 40.1% 39.38%
Depreciation & Amortization $4.715M $3.738M
YoY Change 26.14% 24.19%
% of Gross Profit 13.22% 14.47%
Operating Expenses $47.64M $33.92M
YoY Change 40.45% 30.29%
Operating Profit -$11.98M -$8.077M
YoY Change 48.27% -9.45%
Interest Expense $316.0K $1.235M
YoY Change -74.41% -614.58%
% of Operating Profit
Other Income/Expense, Net $402.0K -$776.0K
YoY Change -151.8% 762.22%
Pretax Income -$11.17M -$9.672M
YoY Change 15.5% 4.56%
Income Tax $800.0K $100.0K
% Of Pretax Income
Net Earnings -$11.99M -$9.727M
YoY Change 23.27% 4.48%
Net Earnings / Revenue -19.05% -21.35%
Basic Earnings Per Share
Diluted Earnings Per Share -$125.7K -$107.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.6M $67.10M
YoY Change 73.75%
Cash & Equivalents $22.50M $21.36M
Short-Term Investments $94.08M $47.60M
Other Short-Term Assets $82.20M $11.20M
YoY Change 633.93%
Inventory
Prepaid Expenses
Receivables $43.02M $28.70M
Other Receivables $0.00 $0.00
Total Short-Term Assets $241.8M $107.0M
YoY Change 126.01%
LONG-TERM ASSETS
Property, Plant & Equipment $69.07M $47.40M
YoY Change 45.72%
Goodwill $348.0K
YoY Change
Intangibles $1.089M
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.51M $8.400M
YoY Change 37.05%
Total Long-Term Assets $82.02M $56.70M
YoY Change 44.65%
TOTAL ASSETS
Total Short-Term Assets $241.8M $107.0M
Total Long-Term Assets $82.02M $56.70M
Total Assets $323.8M $163.7M
YoY Change 97.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.457M $3.900M
YoY Change 142.49%
Accrued Expenses $20.22M $10.70M
YoY Change 88.95%
Deferred Revenue $852.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.291M $12.80M
YoY Change -58.66%
Total Short-Term Liabilities $40.40M $32.70M
YoY Change 23.54%
LONG-TERM LIABILITIES
Long-Term Debt $26.04M $39.40M
YoY Change -33.9%
Other Long-Term Liabilities $1.357M $5.600M
YoY Change -75.77%
Total Long-Term Liabilities $27.40M $45.00M
YoY Change -39.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.40M $32.70M
Total Long-Term Liabilities $27.40M $45.00M
Total Liabilities $67.80M $77.70M
YoY Change -12.75%
SHAREHOLDERS EQUITY
Retained Earnings -$204.0M
YoY Change
Common Stock $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $255.8M -$133.6M
YoY Change
Total Liabilities & Shareholders Equity $323.8M $163.7M
YoY Change 97.83%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$11.99M -$9.727M
YoY Change 23.27% 4.48%
Depreciation, Depletion And Amortization $4.715M $3.738M
YoY Change 26.14% 24.19%
Cash From Operating Activities -$7.186M -$10.08M
YoY Change -28.73% 89.17%
INVESTING ACTIVITIES
Capital Expenditures $10.17M $4.025M
YoY Change 152.65% -182.99%
Acquisitions
YoY Change
Other Investing Activities $21.40M $1.190M
YoY Change 1698.32% -57.95%
Cash From Investing Activities $9.794M -$3.594M
YoY Change -372.51% 78.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.714M -$1.923M
YoY Change -293.14% 1379.23%
NET CHANGE
Cash From Operating Activities -$7.186M -$10.08M
Cash From Investing Activities $9.794M -$3.594M
Cash From Financing Activities $3.714M -$1.923M
Net Change In Cash $6.359M -$15.61M
YoY Change -140.74% 108.94%
FREE CASH FLOW
Cash From Operating Activities -$7.186M -$10.08M
Capital Expenditures $10.17M $4.025M
Free Cash Flow -$17.36M -$14.11M
YoY Change 23.02% 2839.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001517413
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1816000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1821000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
20300000 USD
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00002
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
CY2019Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2020Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-38897
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
FASTLY, INC.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-5411834
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
475 Brannan Street, Suite 300
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94107
CY2020Q1 dei City Area Code
CityAreaCode
844
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
432-7859
CY2020Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.00002 par value
CY2020Q1 dei Trading Symbol
TradingSymbol
FSLY
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22501000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16142000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
94084000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
114967000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43017000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37136000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
70087000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
70087000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12139000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10991000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
241828000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
249323000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69069000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60037000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
348000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
372000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1089000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1125000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11512000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10112000 USD
CY2020Q1 us-gaap Assets
Assets
323846000 USD
CY2019Q4 us-gaap Assets
Assets
320969000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9457000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4602000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20218000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19878000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5291000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4472000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5430000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8169000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
40396000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37121000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26043000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25158000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1357000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1038000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
67796000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
63317000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
459360000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
449463000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
687000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
196000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-203999000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192009000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
256050000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
257652000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
323846000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
320969000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
62924000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45556000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
27265000 USD
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
19718000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
35659000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
25838000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14298000 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10176000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19168000 USD
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15039000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14169000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8700000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
47635000 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
33915000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11976000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8077000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
719000 USD
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
416000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
316000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
1235000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
402000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-776000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11171000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9672000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
819000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-11990000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-9727000 USD
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95401000 shares
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25290000 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-11990000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-9727000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
13000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
27000 USD
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
478000 USD
CY2019Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
29000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
491000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11499000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9671000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
257652000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3174000 USD
CY2020Q1 fsly Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
146000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6577000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
507000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-11990000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
491000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
256050000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-131927000 USD
CY2019Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
5727000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
639000 USD
CY2019Q1 fsly Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
155000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1467000 USD
CY2019Q1 fsly Stockholders Equity Note Repayment
StockholdersEquityNoteRepayment
12000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-9727000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-133598000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-11990000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-9727000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4715000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3738000 USD
CY2020Q1 fsly Amortization Of Deferred Rent
AmortizationOfDeferredRent
204000 USD
CY2019Q1 fsly Amortization Of Deferred Rent
AmortizationOfDeferredRent
17000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
19000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
159000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6329000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1467000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
150000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
602000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2019Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
706000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
39000 USD
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
224000 USD
CY2020Q1 fsly Interest Paidon Capital Lease
InterestPaidonCapitalLease
119000 USD
CY2019Q1 fsly Interest Paidon Capital Lease
InterestPaidonCapitalLease
77000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-36000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6031000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4586000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1148000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
931000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1400000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1860000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3112000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1686000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-582000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1495000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-507000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7186000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10083000 USD
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2019Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
20088000 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3578000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
21400000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
17700000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10221000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4025000 USD
CY2020Q1 us-gaap Payments For Software
PaymentsForSoftware
1437000 USD
CY2019Q1 us-gaap Payments For Software
PaymentsForSoftware
759000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9742000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3594000 USD
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2488000 USD
CY2020Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1541000 USD
CY2019Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
336000 USD
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2133000 USD
CY2019Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3174000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
639000 USD
CY2020Q1 fsly Proceeds From Stock Options Exercised Early
ProceedsFromStockOptionsExercisedEarly
0 USD
CY2019Q1 fsly Proceeds From Stock Options Exercised Early
ProceedsFromStockOptionsExercisedEarly
250000 USD
CY2020Q1 fsly Proceeds From Repayment Of Stockholders Note
ProceedsFromRepaymentOfStockholdersNote
0 USD
CY2019Q1 fsly Proceeds From Repayment Of Stockholders Note
ProceedsFromRepaymentOfStockholdersNote
12000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3766000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1923000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6359000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15608000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86229000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36963000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92588000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21355000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
155000 USD
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
1446000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
814000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 USD
CY2019Q1 fsly Vestingof Early Exercised Stock Options
VestingofEarlyExercisedStockOptions
155000 USD
CY2020Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3226000 USD
CY2019Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
4082000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5628000 USD
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
32000 USD
CY2020Q1 fsly Vestingof Early Exercised Stock Options
VestingofEarlyExercisedStockOptions
146000 USD
CY2020Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
0 USD
CY2019Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
5727000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
248000 USD
CY2019Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22501000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21355000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
70087000 USD
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92588000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21355000 USD
CY2020Q1 us-gaap Nature Of Operations
NatureOfOperations
Nature of Business<div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fastly, Inc. has built an edge cloud platform that can process, serve, and secure its customer’s applications as close to their end users as possible. As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, our edge network spans </span><span style="font-family:inherit;font-size:10pt;"><span>72</span></span><span style="font-family:inherit;font-size:10pt;"> Points-of-Presence ("POPs") across </span><span style="font-family:inherit;font-size:10pt;">55</span><span style="font-family:inherit;font-size:10pt;"> markets around the world. We were incorporated in Delaware in 2011 and are headquartered in San Francisco, California.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As used herein, "Fastly," "we," "our," "the Company," and similar terms include Fastly, Inc. and its subsidiaries, unless the context indicates otherwise.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Split</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On May 3, 2019, we implemented a 1-for-</span><span style="font-family:inherit;font-size:10pt;">2</span><span style="font-family:inherit;font-size:10pt;"> reverse stock split of our stock. All shares of common stock, stock-based instruments, and per-share data included in these financial statements give effect to the stock split and the changes in authorized shares have been adjusted retroactively for all periods presented.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Initial Public Offering ("IPO")</span></div><span style="font-family:inherit;font-size:10pt;">On May 21, 2019 we completed an IPO in which we sold </span><span style="font-family:inherit;font-size:10pt;"><span>12,937,500</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our newly authorized Class A common stock, which included </span><span style="font-family:inherit;font-size:10pt;"><span>1,687,500</span></span><span style="font-family:inherit;font-size:10pt;"> shares sold pursuant to the exercise by the underwriters of an option to purchase additional shares, at the public offering price of </span><span style="font-family:inherit;font-size:10pt;"><span>$16.00</span></span><span style="font-family:inherit;font-size:10pt;"> per share. We received net proceeds of </span><span style="font-family:inherit;font-size:10pt;"><span>$192.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, after deducting underwriting discounts and commissions, from sales of our shares in the IPO. The net proceeds include additional proceeds of </span><span style="font-family:inherit;font-size:10pt;"><span>$25.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of underwriters' discounts and commissions, from the exercise of the underwriters' option to purchase an additional </span><span style="font-family:inherit;font-size:10pt;"><span>1,687,500</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our Class A common stock. Prior to the closing of the IPO, all shares of common stock then outstanding were reclassified as Class B common stock. Immediately upon the closing of the IPO, all shares of convertible preferred stock then outstanding were converted into </span><span style="font-family:inherit;font-size:10pt;"><span>53,630,213</span></span><span style="font-family:inherit;font-size:10pt;"> shares of Class B common stock on a </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span>-to-one basis.
CY2020Q1 fsly Pointsof Presence
PointsofPresence
72 location
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The interim unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") along with instructions to Form 10-Q and Article 10 of Securities and Exchange Commission ("SEC") Regulation S-X. </span></div>
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments, and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. Actual results and outcomes could differ significantly from our estimates, judgments, and assumptions. Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to revenue, accounts receivable and related reserves, useful lives and realizability of long-lived assets, income tax reserves, and accounting for stock-based compensation. Estimates are periodically reviewed in light of changes in circumstances, facts, and experience. The effects of material revisions in estimates are reflected in the condensed consolidated financial statements in the period of change and prospectively from the date of the change in estimate.The ongoing global COVID-19 pandemic has impacted many operational aspects of our business and may continue to do so in the future. We assessed the impact that COVID-19 had on our results of operations, including, but not limited to an assessment of our allowance for doubtful accounts, the carrying value of short-term and long-term investments, the carrying value of goodwill and other long-lived assets, and the impact to revenue recognition and cost of revenues. While the COVID-19 pandemic has not had a material adverse impact on our financial operations to date, the future impacts of the pandemic and any resulting economic impact are largely unknown and rapidly evolving. We will continue to actively monitor the impact that COVID-19 has on the results of our business operations, and may make decisions required by federal, state or local authorities, or that are determined to be in the best interests of our employees, customers, partners, suppliers and stockholders. As a result our estimates and judgments may change materially as new events occur or additional information becomes available to us.</span></div>
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
178000 USD
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
936000 USD
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Credit Risk</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The primary focus of our investment strategy is to preserve capital and meet liquidity requirements. Our investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage the risk exposure, we invest cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. We place our cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.</span></div><span style="font-family:inherit;font-size:10pt;">Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which we make substantial sales. Our customer base consists of a large number of geographically dispersed customers diversified across several industries. To reduce risk, we routinely assess the financial strength of our customers. Based on such assessments, we believe that our accounts receivable credit risk exposure is limited. One customer accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>10.5%</span></span><span style="font-family:inherit;font-size:10pt;"> of revenue for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>14.6%</span></span><span style="font-family:inherit;font-size:10pt;"> of the total accounts receivable balance as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. No customer accounted for more than 10% of revenue for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, or more than 10% of the total accounts receivable balance as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span>
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
62924000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45556000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
62924000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45556000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
305000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
271000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
852000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
317000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
71000000.0 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.88
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2019Q4 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P5Y
CY2020Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
7944000 USD
CY2019Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
6804000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
700000 USD
CY2019Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
500000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22501000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16142000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
94084000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
114967000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
93509000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
607000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
32000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
94084000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
114870000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
98000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
114967000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2020Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
341000 USD
CY2020Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13998000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
94084000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
70087000 USD
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
178169000 USD
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4519000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
114967000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
70087000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
189573000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
121752000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
108276000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52683000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48239000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69069000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60037000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
4700000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
3700000 USD
CY2019Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
634000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9666000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8734000 USD
CY2020Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4500000 USD
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3938000 USD
CY2020Q1 fsly Accrued Colocation And Bandwidth Costs
AccruedColocationAndBandwidthCosts
2519000 USD
CY2019Q4 fsly Accrued Colocation And Bandwidth Costs
AccruedColocationAndBandwidthCosts
3237000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3533000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3969000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20218000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19878000 USD
CY2020Q1 fsly Liability For Early Exercised Stock Options Current
LiabilityForEarlyExercisedStockOptionsCurrent
385000 USD
CY2019Q4 fsly Liability For Early Exercised Stock Options Current
LiabilityForEarlyExercisedStockOptionsCurrent
467000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
852000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
317000 USD
CY2020Q1 fsly Accrued Computer And Networking Equipment
AccruedComputerAndNetworkingEquipment
3896000 USD
CY2019Q4 fsly Accrued Computer And Networking Equipment
AccruedComputerAndNetworkingEquipment
7060000 USD
CY2020Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
297000 USD
CY2019Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
325000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5430000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8169000 USD
CY2020Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1016000 USD
CY2019Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
404000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1357000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1038000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
372000 USD
CY2020Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-24000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
348000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1487000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
398000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1089000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1487000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
362000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1125000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
119000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
158000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
158000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
148000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
145000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
361000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1089000 USD
CY2020Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
11200000 USD
CY2019Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
9500000 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
20300000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
20300000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
20300000 USD
CY2020Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
200000 USD
CY2019Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
219000 USD
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
20100000 USD
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
20081000 USD
CY2020Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
11234000 USD
CY2019Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
9549000 USD
CY2020Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
5291000 USD
CY2019Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
4472000 USD
CY2020Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5943000 USD
CY2019Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5077000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26043000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25158000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3704000 USD
CY2020Q1 fsly Long Term Debt And Capital Lease Obligations Maturities Interest Due Remainder Of Fiscal Year
LongTermDebtAndCapitalLeaseObligationsMaturitiesInterestDueRemainderOfFiscalYear
1867000 USD
CY2020Q1 fsly Longterm Debtand Capital Lease Obligations Maturities Total Payments Due Remainderof Fiscal Year
LongtermDebtandCapitalLeaseObligationsMaturitiesTotalPaymentsDueRemainderofFiscalYear
5571000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
4838000 USD
CY2020Q1 fsly Long Term Debt And Capital Lease Obligations Maturities Interest Due Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesInterestDueYearTwo
2072000 USD
CY2020Q1 fsly Longterm Debtand Capital Lease Obligations Maturities Total Payments Due Year Two
LongtermDebtandCapitalLeaseObligationsMaturitiesTotalPaymentsDueYearTwo
6910000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
22758000 USD
CY2020Q1 fsly Long Term Debt And Capital Lease Obligations Maturities Interest Due Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesInterestDueYearThree
21140000 USD
CY2020Q1 fsly Longterm Debtand Capital Lease Obligations Maturities Total Payments Due Year Three
LongtermDebtandCapitalLeaseObligationsMaturitiesTotalPaymentsDueYearThree
43898000 USD
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3200000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
234000 USD
CY2020Q1 fsly Long Term Debt And Capital Lease Obligations Maturities Interest Due Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesInterestDueYearFour
2000 USD
CY2020Q1 fsly Longterm Debtand Capital Lease Obligations Maturities Total Payments Due Year Four
LongtermDebtandCapitalLeaseObligationsMaturitiesTotalPaymentsDueYearFour
236000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2020Q1 fsly Long Term Debt And Capital Lease Obligations Maturities Interest Due Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesInterestDueYearFive
0 USD
CY2020Q1 fsly Longterm Debtand Capital Lease Obligations Maturities Total Payments Due Year Five
LongtermDebtandCapitalLeaseObligationsMaturitiesTotalPaymentsDueYearFive
0 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
0 USD
CY2020Q1 fsly Long Term Debt And Capital Lease Obligations Maturities Interest Due Year After Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesInterestDueYearAfterFive
0 USD
CY2020Q1 fsly Longterm Debtand Capital Lease Obligations Maturities Total Payments Due Year After Five
LongtermDebtandCapitalLeaseObligationsMaturitiesTotalPaymentsDueYearAfterFive
0 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
31534000 USD
CY2020Q1 fsly Long Term Debt And Capital Lease Obligations Interest Due
LongTermDebtAndCapitalLeaseObligationsInterestDue
25081000 USD
CY2020Q1 fsly Longterm Debtand Capital Lease Obligations Maturities Total Payments Due
LongtermDebtandCapitalLeaseObligationsMaturitiesTotalPaymentsDue
56615000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
300000 USD
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1200000 USD
CY2020Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2300000 USD
CY2019Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000 USD
CY2020Q1 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
300000 USD
CY2019Q1 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
300000 USD
CY2020Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
33184000 USD
CY2020Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
13290000 USD
CY2020Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
4790000 USD
CY2020Q1 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
284000 USD
CY2020Q1 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
72000 USD
CY2020Q1 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
0 USD
CY2020Q1 us-gaap Purchase Obligation
PurchaseObligation
51620000 USD
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.10
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2300000 USD
CY2018Q4 fsly Convertible Preferred Stock Number Of Series
ConvertiblePreferredStockNumberOfSeries
7 series_of_stock
CY2018Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00002
CY2020Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000.0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11269000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.68
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
173471000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1107000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.68
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
61000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.94
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10101000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.89
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
142692000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
6443000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.00
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y4M24D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
102947000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20200000 USD
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1400000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
16200000 USD
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
163305 shares
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
199895 shares
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6329000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1467000 USD
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13422000 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62482000 shares
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69069000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60037000 USD

Files In Submission

Name View Source Status
0001517413-20-000094-index-headers.html Edgar Link pending
0001517413-20-000094-index.html Edgar Link pending
0001517413-20-000094.txt Edgar Link pending
0001517413-20-000094-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fsly-10qx33120.htm Edgar Link pending
fsly-10qx33120_htm.xml Edgar Link completed
fsly-20200331.xsd Edgar Link pending
fsly-20200331_cal.xml Edgar Link unprocessable
fsly-20200331_def.xml Edgar Link unprocessable
fsly-20200331_lab.xml Edgar Link unprocessable
fsly-20200331_pre.xml Edgar Link unprocessable
fsly-33120x10qexhibit311.htm Edgar Link pending
fsly-33120x10qexhibit312.htm Edgar Link pending
fsly-33120x10qexhibit321.htm Edgar Link pending
fsly-33120x10qexhibit322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending